baber/WOPTO huggingface dataset:
Patent AT-E393824-T1 (AT)
Inventor: COIA GREGORY
IPC: G01N33/50
Filed: 1999-03-05
Granted: 2008-05-15
Abstract: The present invention relates to binding moieties comprising at least one monomeric V-like domain (VLD) derived from a non-antibody ligand, the at least one monomeric V-like domain being characterised in that at least one CDR loop structure or part thereof is modified or replaced such that the solubility of the modified VLD is improved when compared with the unmodified VLD.
Patent AT-E333896-T1 (AT)
Inventor: KISHIMOTO TADAMITSU
IPC: A61K38/17
Filed: 1999-03-23
Granted: 2006-08-15
Abstract: Use of a substance that potentiates the action due to CXCR4 selected from the group consisting of SDF-1 and CXCR-4, in the manufacture of a medicament for repairing a tissue.
Patent AT-E225973-T1 (AT)
Inventor: SLASSI TARIK
IPC: G07F7/12
Filed: 1999-05-10
Granted: 2002-10-15
Abstract: A method of authenticating a personal code of a user of an integrated circuit card received in a reader fitted with a keypad, connected to a computer, and capable of accepting at least one type of card. Formatting instructions are transmitted from the computer to the reader that correspond to the type of the card. A command is sent for authenticating the personal code and the authentication command is verified in the reader. For a qualified authentication command, the reader is put into a secure mode which blocks anyone with fraudulent intentions from intervening in the procedure to obtain the personal code. The personal code is then inputted via the keypad of the reader, formatted for the particular type of card used, and the formatted code and the command for authenticating it are transmitted from the reader to the integrated circuit of the card. The card compares the formatted code with a pre-stored personal code.
Patent AT-E251191-T1 (AT)
Inventor: KREYENSCHMIDT MARTIN
IPC: C08G18/08
Filed: 1999-07-21
Granted: 2003-10-15
Abstract: The present invention relates to a mixture that contains (i) at least one isocyanate and (ii) at least one organic and/or inorganic acid anhydride.
Patent AT-E294005-T1 (AT)
Inventor: O'DEA JOHN
IPC: A61M16/12
Filed: 1999-09-03
Granted: 2005-05-15
Abstract: A CPAP controller that supplies oxygen enriched air to a respiratory circuit that utilizes a venturi-jet arrangement within a chamber, which enriches ambient air. Ambient air is drawn into the chamber by a primary oxygen flow source via an oxygen jet that directs oxygen into the venturi. Besides the conventional ability to adjust oxygen/air ratio via changes in the primary oxygen flow source's flow rate adjustment, the oxygen/air ratio may be altered by way of a secondary oxygen supply and its own flow control adjustment that is independent of the primary oxygen source and its adjustment mechanism. Hence the oxygen/air ratio may be adjusted independently of the primary oxygen source's flow rate. The controller further includes a pressure adjustment mechanism that allows the user to adjust pressure to the demand and/or need of the patient.
Patent AT-E239126-T1 (AT)
Inventor: MICKELAT THOMAS
IPC: D21D5/16
Filed: 1999-09-14
Granted: 2003-05-15
Abstract: A screening device includes a screening element connected to a reinforcing element by a frictionally engaging clamping connection. Spacers located between the screening element and the reinforcing element provide a radial clearance therebetween. The screening element can be replaced when worn out, while the reinforcing element and associated parts can be reused with a new screening device. For this purpose, the screening element can be detached from the reinforcing element, which provides the actual support function, as a single unit by way of the frictionally engaging clamping connection. The clamping connection can be implemented by way of wedges or a conical seat.
Patent AT-E289838-T1 (AT)
Inventor: HAMMARSTROEM OLA
IPC: G01L7/00
Filed: 1999-12-22
Granted: 2005-03-15
Abstract: A sensor and guide wire assembly includes a core wire having a distal end, a proximal end, and a plurality of sections of different cross sections and thereby different flexibilities. At least one of the core wire sections has an enlarged portion with a sensor receptacle therein. The assembly also includes a tube that encloses the core wire over at least a fraction of its length such that the core wire extends out from a distal end of the tube. The tube is configured to enable the sensor and guide wire assembly to be inserted into an artery and to be passed to a measurement site inside a patient's body. The assembly further includes a sensor mounted in the sensor receptacle of the enlarged portion of the core wire. A first coil is arranged to enclose a first portion of the core wire extending out from the distal end of the tube, and the first coil is located nearer to the proximal end of the core wire than the sensor. A second coil is arranged to enclose a second portion of the core wire extending out from the distal end of the tube. The second coil is located nearer to the distal end of the core wire than the sensor.
Patent AT-E291018-T1 (AT)
Inventor: BROWN BRADLEY B
IPC: A61K31/4439
Filed: 1999-12-21
Granted: 2005-04-15
Abstract: The present invention is directed to compounds of the formula:and pharmaceutically acceptable salts thereof, to pharmaceutical compositions comprising same, and to methods for inhibiting protein prenylation in an organism using the same, where R1, R2, R3, R4, R5, R6, R7 and X are defined herein.
Patent AT-E333904-T1 (AT)
Inventor: DELMOTTE YVES
IPC: C12M3/04
Filed: 1999-11-04
Granted: 2006-08-15
Abstract: An element provided with a layer based on fibrin- or fibrinogen-containing material, said element comprising (a) a hydrophobic or substantially hydrophobic support, which has a porous part with a thickness of 0.1 to 5 mm, and whose pores, extending across its thickness have a node spacing of 5 to 100 mum, one face of said porous part being treated with a compound based on fibrin and/or a fibrinogen-containing material, and (b) a fibrin-based layer covering said treated surface of the support, characterized in that said fibrin-based layer is substantially uniform and homogeneous on said treated surface, and that the fibrin layer and at least the face of the support in contact with the fibrin layer are substantially free of fibrinogen.
Patent AT-E287752-T1 (AT)
Inventor: AKAE YUKOH
IPC: A62D3/33
Filed: 1999-11-15
Granted: 2005-02-15
Abstract: Hazardous compounds are chemically treated to remove various pollutants by subjecting the compounds (samples) to various process steps, including selecting specific solvents and using them, treating the sample at room temperature or below (30  DEG C or lower); separating fatty acids mixed with heavy metal and semi-metal compounds as well as the separation of organic substances (including halogenated compounds) added to heavy metals and semi-metals; and using sodium nitrite and sodium 1-naphthylamine-4-sulfonate in combination from specific solvents, thereby forming alkylsulfonic acid salt and alkyl sulfonium salt in the presence of sulfonic acid salt so as to fix organic substances mixed in the sample.
Patent DE-179678-T1 (DE)
IPC: G01F11/28
Filed: 1985-09-02
Abstract: The invention relates to a process and an apparatus for the transfer and dispensing of brittle solid particles, the apparatus comprises a transfer and dispensing device including a chamber divided into first and second sections by a transverse partition wall provided with one or several holes, of a diameter smaller than that of the solid particles, the two sections communicating with one another through said holes. The first section is a dispensing section proper, ending at its lower end with an opening defined by the open lower end of said chamber, wherreas the second suction or discharge section, cooperates with a suction and discharge device. The apparatus ensures an accurate proportioning and a high rate of introduction of the solid particles into bottles, reaching 25000 bottles per hour, without damaging them.
Patent DE-352713-T1 (DE)
IPC: G01N33/533
Filed: 1989-07-24
Abstract: A 1,2-dioxetane of the formulaand an alkene of the formulaare described. The 1,2-dioxetane is useful in immunoassays and in DNA probes used for various purposes.
Patent DE-942811-T1 (DE)
Inventor: LOEWERT CLAUDE
IPC: A47B13/16
Filed: 1997-11-27
Abstract: The invention concerns a mounting and/or assembling station, used by an operator for carrying out predetermined repetitive tasks during the manufacture of a product, and for improving the productivity and the comfort of the operator. The mounting and/or assembling station (1') is characterised in that it comprises a working area (2) of three-dimensional structure with several storing, supporting and transferring zones associated with working zones, said zones being defined by the skew surfaces delimiting variable integrated volumes enabling the operator to carry out various functional tasks, such as machining, controlling or the like. Said storing, supporting and transferring zones are optimally arranged relative to the working zones for reducing the distance to cover between the different zones and the time taken for carrying out the functional tasks.
Patent ES-2310161-T1 (ES)
Title: Sistema y procedimiento de interfaz externa de paciente.
Inventor: BUBB STEPHEN K
IPC: A61M1/00
Filed: 2006-10-03
Abstract: Conjunto de vendaje para una herida o incisión, que comprende: una interfaz externa de paciente que incluye un componente externo de transferencia de fluido, estando adaptado dicho componente de transferencia de fluido para transferir fluido desde la herida o incisión; incluyendo dicha interfaz externa de paciente un sobrevendaje colocado sobre dicho componente de transferencia de fluido en contacto con una superficie cutánea circundante; e incluyendo dicho componente de transferencia de fluido un núcleo poroso con una superficie y una capa de material de efecto de mecha que se engancha al mismo.
Patent ES-2030382-T1 (ES)
Title: Procedimiento para manipular productos de imprenta que se presentan en una formacion imbricada.
IPC: B65H31/00
Filed: 1991-06-29
Abstract: BASANDOSE EN LOS PRODUCTOS DE IMPRENTA (10), QUE APARECEN CON UNA DISTANCIA CASI IGUAL B DENTRO DE LA FORMACION ESCAMOSA S DE LA LONGITUD C, SE FORMA LA FORMACION ESCAMOSA S1, MEDIANTE LA INTRODUCCION CONJUNTA DE LOS PRODUCTOS DE IMPRENTA (10), AL REDUCIR EN EL MISMO TIEMPO LA DISTANCIA ESCAMOSA B, B1. ESTA FORMACION SE ARROLLA COMO UN PAQUETE DE RODILLO EN CONJUNTO CON LA ENVOLTURA (28). EN LA UTILIZACION FINAL SE DESENVUELVE EL PAQUETE Y LA FORMACION S1 ESCAMOSA SE INTRODUCEN CONSECUTIVAMENTE EN LA PILA. CON ESTE FIN LA LONGITUD DE LA FORMACION C1 HA SIDO ELEGIDA DE TAL FORMA QUE LA MISMA PERSONA PUEDE AGARRAR CON LAS MANOS LOS EXTREMOS (22 Y 24) AL MISMO TIEMPO. CADA UNO DE ESTOS PRODUCTOS DE IMPRENTA (10) SE EXTRAEN ENTONCES DE LA PILA.
Patent ES-2100141-T1 (ES)
Title: Ensayo biologico para contaminacion microbiana.
Inventor: ISBISTER JENEFIR D
IPC: C12Q1/06
Filed: 1995-05-22
Abstract: SE PROPORCIONAN METODOS Y KITS PARA DETECTAR LA PRESENCIA Y CUANTIFICAR LA CONCENTRACION DE MICROORGANISMOS VIABLES EN UNA MUESTRA LIQUIDA. LAS ENZIMAS PRESENTES EN MICROORGANISMOS VIABLES REDUCEN UN REACTIVO INDICADOR PARA PRODUCIR UN CAMBIO DE COLOR VISIBLE. NO SON NECESARIAS TITULACIONES O DILUCIONES DE LA MUESTRA. SE DESCRIBEN VARIACIONES DE LA PRUEBA QUE PUEDEN UTILIZARSE PARA DETECTAR UN NIVEL DE UMBRAL DE MICROORGANISMOS VIABLES, PARA DETECTAR LA PRESENCIA O AUSENCIA DE MICROORGANISMOS VIABLES Y PARA CUANTIFICAR LA CONCENTRACION DE MICROORGANISMOS VIABLES EN UNA MUESTRA LIQUIDA. LOS RESULTADOS SE OBTIENEN RAPIDAMENTE CON AQUELLOS PARA LA DETECCION DISPONIBLES EN TREINTA MINUTOS Y AQUELLOS PARA LA CUANTIFICACION DISPONIBLES EN TRECE HORAS.
Patent CY-1111293-T1 (CY)
Inventor: WARE CARL F
IPC: C12N15/62
Filed: 2010-12-29
Abstract: A novel polypeptide ligand, p30, or LIGHT, for herpes virus entry mediator, HVEM, is provided. p30 is useful for modulating immune responses and in inhibiting infection and/or subsequent proliferation by herpes virus. HVEM fusion proteins are also provided. Methods for treating subjects with lymphoid cell disorders, tumors, autoimmune diseases, inflammatory disorders of those having or suspected of having a herpes virus infection, utilizing p30 and the fusion proteins of the invention, are also provided.
Patent CY-1111496-T1 (CY)
Inventor: QIAN CHENG
IPC: C12N15/861
Filed: 2011-01-31
Abstract: The present invention relates to a genic expression adenoviral hybrid vector  characterized in that  it contains at least the following elements, oriented in the direction 5' to 3': i. a first chain of adenoviral origin comprising a first inverted terminal repeat (ITR) sequence and a signal sequence for packaging of the adenovirus; ii. a first non-encoding stuffer sequence; iii. a sequence corresponding to a tissue specific promoter; iv. a chain of cDNA derived from an alphavirus, the sequence of which is partly complementary to an alphaviral RNA sequence, comprising at least a sequence encoding for at least one exogenous gene of interest; v. a polyadenylation sequence; and vi. a second adenoviral inverted terminal repeat (ITR) sequence, it preferably relates to an adenoviral hybrid vector comprising as exogenous gene of interest the therapeutic gene of mammalian interleukin IL-12 and even more preferably human interleukin hIL-12; and to the use of the hybrid vector in a process for transferring genetic material to a cell, particularly a tumor cell that preferably expresses alpha-fetoprotein (AFP), and to its use for inducing an immune response against foreign antigens.
Patent CY-1115677-T1 (CY)
Title: Ολοκληρωμενο συστημα κινησης ανεμιστηρα για πυργο ψυξης και μεθοδος λειτουργιας πυργου ψυξης υγρων
Inventor: ROLLINS PATRICK M
IPC: F04D27/00
Filed: 2014-09-16
Abstract: Ένα ολοκληρωμένο σύστημα κίνησης ανεμιστήρα για ένα πύργο ψύξης που περιλαμβάνει ένα υψηλής ροπής κινητήρα μόνιμου μαγνήτη που έχει ένα άξονα που μπορεί να περιστρέφεται, ένα ανεμιστήρα που περιλαμβάνει ένα αφαλό που συνδέεται απευθείας στον άξονα που μπορεί να περιστρέφεται και ένα πλήθος πτερυγίων ανεμιστήρα που είναι προσαρτημένα στον αφαλό, και μία συσκευή κίνησης μεταβλητής συχνότητας σε επικοινωνία ηλεκτρικού σήματος με τον κινητήρα μόνιμου μαγνήτη για τον έλεγχο της ταχύτητας περιστροφής του κινητήρα μόνιμου μαγνήτη. Ο υψηλής ροπής, κινητήρας μόνιμου μαγνήτη περιλαμβάνει όχι περισσότερα από δύο έδρανα που συνδυάζονται λειτουργικά με τον άξονα. Η συσκευή κίνησης μεταβλητής συχνότητας έχει ένα ελεγκτή μεταβλητής συχνότητας που έχει μία είσοδο για την λήψη ισχύος εναλλασσόμενου ρεύματος (AC) και μία έξοδο για την παροχή ηλεκτρικών σημάτων που ελέγχουν την ταχύτητα περιστροφής του κινητήρα υψηλής ροπής, μόνιμου μαγνήτη. Η συσκευή κίνησης μεταβλητής συχνότητας περιλαμβάνει επίσης μία διεπαφή (interface) χρήστη με επικοινωνία σήματος δεδομένων με τον ελεγκτή μεταβλητής συχνότητας ώστε να επιτρέπει σε ένα χρήστη να εισάγει δεδομένου ελέγχου ταχύτητας του κινητήρα.
Patent CY-1118015-T1 (CY)
Inventor: BREHM WINFRIED
IPC: A61J1/20
Filed: 2016-09-15
Abstract: The invention relates to the field of connectors for connecting a container with a fluid preparation device for preparing a fluid, in particular a container with a concentrate for the preparation of dialysis fluid. In order to simplify the handling during both the manufacturing process of such containers and the connection of such containers to the fluid preparation devices, the invention proposes a design of a connector (1) for connecting a first and second fluid line of the container with a third and fourth fluid line of the fluid preparation device with two lateraly spaced-apart mounting means (2, 4) which each incorporate one of two orifices (3, 5) terminating the first and second fluid lines. The invention also concerns a corresponding container and fluid preparation device.
Patent CY-1118129-T1 (CY)
Title: 5-αλκυνυλ-πυριμιδινες
Inventor: SCHNEIDER SIEGFRIED
IPC: C07D405/14
Filed: 2016-10-19
Abstract: Η παρούσα εφεύρεση συμπεριλαμβάνει ενώσεις του γενικού τύπου (1), όπου R1 έως R3 ορίζονται όπως στην αξίωση 1, οι οποίες είναι κατάλληλες για τη θεραπεία ασθενειών που χαρακτηρίζονται από εκτεταμένο ή μη κανονικό πολλαπλασιασμό κυττάρου, και τη χρήση αυτών για παρασκευή φαρμάκου που έχει τις ανωτέρω-αναφερθείσες ιδιότητες.
Patent CY-1120887-T1 (CY)
Title: Αντισωματα που προσδενουν il-4 και/ή il-13 και οι χρησεις τους
Inventor: RAO ERCOLE
IPC: A61K39/395
Filed: 2018-07-17
Abstract: Η παρούσα εφεύρεση αφορά νέα εξανθρωπισμένα αντι-IL-4 και IL-13 αντισώματα και κλάσματα αυτών και νέα αμφιειδικά αντισώματα και κλάσματα αυτών, που προσδένονται ειδικώς σε IL-4 και IL-13. Η εφεύρεση συμπεριλαμβάνει επίσης χρήσεις των αντισωμάτων στην αντιμετώπιση ή πρόληψη μεσολαβούμενων από IL-4 και/ή IL-13 ασθενειών ή διαταραχών, συμπεριλαμβανομένου του αλλεργικού άσθματος και της δερματίτιδας.
Patent CY-1122700-T1 (CY)
Title: Γενετικα τροποποιημενοι ποντικοι εκφραζοντες χιμαιρικα μορια μειζονος συμπλεγματος ιστοσυμβατοτητας (μηc) ii
Inventor: MACDONALD LYNN
IPC: A01K67/027
Filed: 2020-02-26
Abstract: Η εφεύρεση παρέχει γενετικά τροποποιημένα μη ανθρώπινα ζώα, τα οποία εκφράζουν μια ανθρωποποιημένη ΜΗC II πρωτεΐνη (ανθρωποποιημένα ΜΗC II άλφα και βήτα πολυπεπτίδια) καθώς και έμβρυα, κύτταρα και ιστούς που περιέχουν αυτήν την πρωτεΐνη. Παρέχονται επίσης δομές για τη δημιουργία των προαναφερθέντων γενετικά τροποποιημένων ζώων και μέθοδοι για τη δημιουργία τους. Παρέχονται μέθοδοι χρήσης των γενετικά τροποποιημένων ζώων για τη μελέτη διαφόρων παραμέτρων του ανθρώπινου ανοσοποιητικού συστήματος.
Patent CY-1123476-T1 (CY)
Title: Τροποποιητες πυρηνικης μεταφορας και χρησεις αυτων
Inventor: SANDANAYAKA VINCENT P
IPC: C07D403/12
Filed: 2020-06-02
Abstract: Η παρούσα εφεύρεση αφορά ενώσεις του τύπου Ι και φαρμακευτικά αποδεκτά άλατα αυτών, φαρμακευτικές συνθέσεις που περιλαμβάνουν τις ενώσεις του τύπου Ι και μεθόδους χρήσης των εν λόγω ενώσεων, αλάτων και συνθέσεων στην αγωγή διαφόρων διαταραχών που σχετίζονται με τη δραστικότητα CRM1.
Patent CY-1123475-T1 (CY)
Title: Αναστολεις της ειδικης για λυσινη απομεθυλασης-1
Inventor: CHEN YOUNG K
IPC: C07D401/02
Filed: 2020-08-14
Abstract: Η παρούσα εφεύρεση αφορά γενικά συνθέσεις και μεθόδους για την αγωγή καρκίνου και νεοπλασματικής νόσου. Παρέχονται εδώ υποκατεστημένες ετεροκυκλικές παράγωγες ενώσεις και φαρμακευτικές συνθέσεις που περιλαμβάνουν τις ενώσεις αυτές. Οι εν λόγω ενώσεις και συνθέσεις είναι χρήσιμες για αναστολή ειδικής για λυσίνη απομεθυλάσης-1. Περαιτέρω οι εν λόγω ενώσεις και συνθέσεις είναι χρήσιμες για τη θεραπεία του καρκίνου όπως καρκίνου του προστάτη, καρκίνου του μαστού, καρκίνου της ουροδόχου κύστης, καρκίνου του πνεύμονα και/ή μελανώματος και παρομοίων.
Patent CY-1124050-T1 (CY)
Title: Πρωτεϊνες δεσμευσης αντιγονου προσδετη ανθρωπινης cd30
Inventor: ANDERSEN METTE DAHL
IPC: C07K14/28
Filed: 2021-03-03
Abstract: Παρέχονται συνθέσεις και μέθοδοι οι οποίες σχετίζονται με πρωτεΐνες δέσμευσης αντιγόνου ανθρώπινου CD30L. Οι συνθέσεις που περιγράφονται στο παρόν έγγραφο περιλαμβάνουν: πρωτεΐνες δέσμευσης αντιγόνου ανθρώπινου CD30L, πολυνουκλεοτίδια που κωδικοποιούν πρωτεΐνες δέσμευσης αντιγόνου ανθρώπινου CD30L, διαβιβαστές που περιέχουν αυτά τα πολυνουκλεοτίδια, κύτταρα ξενιστές και φαρμακευτικές συνθέσεις. Παρέχονται επίσης μέθοδοι παρασκευής και χρήσης καθεμιάς από αυτές τις συνθέσεις.
Patent CY-1124777-T1 (CY)
Title: Παρασκευη παραγωγων του 2-([1,2,3]τριαζολ-2-υλ)-βενζοϊκου οξεος
Inventor: DÖRRWÄCHTER PATRIC
IPC: C07D249/06
Filed: 2021-10-06
Abstract: Η παρούσα εφεύρεση αναφέρεται σε μία μέθοδο για την παρασκευή συγκεκριμένων παραγώγων του 2-(2Η-[1,2,3]τριαζολ-2-υλ)-βενζοϊκού οξέος του τύπου (Ι), σε ορισμένες κρυσταλλικές μορφές αλάτων με κάλιο των εν λόγω παραγώγων του 2-(2Η-[1,2,3]τριζολ-2-υλ)-βενζοϊκού οξέος του τύπου (Ικ), σε ορισμένες κρυσταλλικές μορφές των εν λόγω παραγώγων του 2-(2Η-[1,2,3]τριαζολ-2-υλ)-βενζοϊκού οξέος του τύπου (Ι) και στη χρήση τους στην παρασκευή φαρμακευτικών προϊόντων όπως η (S)-(2-(5-χλωρο-4-μεθυλο-1Η-βενζο[d]ιμιδαζολ-2-υλ)-2-μεθυλοπυρρολιδιν-1-υλ)-(5-μεθοξυ-2-(2Η-1,2,3-τριαζολ-2-υλ) φαινυλ)μεθανόνη.
Patent HR-P20100682-T1 (HR)
Inventor: FRIEDL THOMAS
IPC: A61K9/28
Filed: 2010-12-09
Abstract: Formulacija tablete produljenog oslobadanja, naznacena time, da sadrzi pramipeksol ili njegovu farmaceutski prihvatljivu sol u matrici koja sadrzi barem dva polimera koja bubre u vodi razlicita od prezelatiniziranog skroba te pri cemu najmanje jedan od barem dva polimera je anionski polimer. Patent sadrzi jos 13 patentnih zahtjeva.
Patent SI-1260615-T1 (SI)
Title: Metal coating of graphite
Inventor: FRANZ WOLF-DIETER
IPC: C25D5/54
Filed: 2001-05-14
Abstract: Applying a metal coating comprises applying a galvanic metal coating to graphite components after they have been subjected to an alkaline anodic caustic bath. An Independent claim is also included for a process for the production of a solder join with a graphite component. Preferred Features: A lead layer is formed on the graphite components before the metal coating is applied. The lead layer is reinforced by the current-less deposition of nickel or copper. The caustic bath has a temperature of 20-70 degrees C.
Patent SI-1742479-T1 (SI)
Title: Multihypothesis B-picture virtual display buffer by stealing space in the H.264 post decoder buffer.
Inventor: LIM CHONG SOON
IPC: H04N21/44
Filed: 2003-07-07
Abstract: An input image is coded and then decoded by referencing an image stored in a picture buffer. The decoded image is checked whether it is a reference image or output image. The decoded image is stored in the picture buffer based upon the checking result. An independent claim is also included for image decoding method.
Patent SI-1720583-T1 (SI)
Title: Apparatus for receiving, storing and providing bags of blood
Inventor: ZENOBI MAURO
IPC: A61M1/00
Filed: 2004-02-09
Abstract: The apparatus for receiving, preserving and supplying bags of blood comprises a cabinet for containing all the components of the apparatus; a refrigerated space for containing the bags; a magazine comprising a plurality of cells, each capable of containing a single bag, the magazine being housed inside the refrigerated space, each of the cells being identified by a cell code; at least one door for allowing access by an operator to the cells; a movement system housed inside the cabinet and capable of moving, preferably rotating, the cells; a cooling system housed inside the cabinet and capable of cooling the refrigerated space; a data processing system housed inside the cabinet, capable of controlling the movement system and the cooling system, and capable of controlling the receiving, preservation and supply of the bags; a keyboard and a screen, both connected to the processing system, and both placed at the walls of the cabinet.
Patent SI-1663217-T1 (SI)
Title: Solid dispersions comprising tacrolimus
Inventor: HOLM PER
IPC: A61K9/14
Filed: 2004-08-30
Abstract: A modified release composition comprising tacrolimus releases less than 20% w/w of the active ingredient within 0.5 hours when subjected to an in vitro dissolution test using USP Paddle method and using 0.1 N HCl as dissolution medium and has increased bioavailability by effectively reducing or even avoiding the effects of CYP3A4 metabolism. The modified composition may be coated with an enteric coating; and/or may comprise a solid dispersion or a solid solution of tacrolimus in a hydrophilic or water-miscible vehicle and one or more modifying release agents; and/or may comprise a solid dispersion or a solid solution of tacrolimus in an amphiphilic or hydrophobic vehicle and optionally one or more modifying release agents.